ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,752 | +74.5% | 14,933 | +159.4% | 0.00% | – |
| Q1 2023 | $57,167 | -90.8% | 5,757 | -95.0% | 0.00% | -100.0% |
| Q3 2022 | $621,000 | +68.8% | 116,285 | +26.0% | 0.00% | +50.0% |
| Q2 2022 | $368,000 | +493.5% | 92,297 | +560.0% | 0.00% | +100.0% |
| Q1 2022 | $62,000 | -81.6% | 13,985 | -83.4% | 0.00% | -66.7% |
| Q4 2021 | $337,000 | -11.3% | 84,342 | +95.0% | 0.00% | -40.0% |
| Q3 2021 | $380,000 | -72.2% | 43,252 | -64.2% | 0.01% | -66.7% |
| Q2 2021 | $1,369,000 | +38.7% | 120,849 | +45.4% | 0.02% | +15.4% |
| Q1 2021 | $987,000 | +494.6% | 83,117 | +242.7% | 0.01% | +550.0% |
| Q4 2020 | $166,000 | +1744.4% | 24,257 | +2000.2% | 0.00% | – |
| Q3 2020 | $9,000 | -89.8% | 1,155 | -92.4% | 0.00% | -100.0% |
| Q4 2019 | $88,000 | +193.3% | 15,150 | +198.7% | 0.00% | +100.0% |
| Q2 2019 | $30,000 | – | 5,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |